STOCK TITAN

Vaso Corp - VASO STOCK NEWS

Welcome to our dedicated news page for Vaso (Ticker: VASO), a resource for investors and traders seeking the latest updates and insights on Vaso.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Vaso's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Vaso's position in the market.

Rhea-AI Summary
Vaso achieves another record in annual revenue, reaching $81.0 million in 2023, a 2.2% increase year-over-year. Net income for the year was $4.8 million, despite significant investments. The Company generated positive cash flow of $5.3 million in 2023. Deferred revenue increased to $32.2 million. Vaso entered into a business combination agreement with Achari Ventures Holdings Corp. I, anticipating a merger and a name change to 'Vaso Holdings Corp.' The Business Combination Agreement values Vaso at approximately $176 million. Financial results for Q4 2023 show a decrease in revenue by 5.6% to $21.9 million, with lower revenues in all segments. Net income for Q4 was $1.1 million, a decrease from the previous year. For the year ended December 31, 2023, revenue increased by 2.2% to $81.0 million. Gross profit increased by 5.6% to $50.6 million, while net income was $4.8 million, a decrease from the previous year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.45%
Tags
-
Rhea-AI Summary
Vaso Corporation (OTCQX:VASO) is merging with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) to uplist to the Nasdaq Stock Market. The transaction values Vaso at a pro forma equity value of approximately $176 million at $10 per share. Upon closing, existing Vaso shareholders will receive consideration consisting entirely of shares of the surviving public combined company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
-
Rhea-AI Summary
Vaso Corporation (OTCQX:VASO) Reports $19.4 Million Revenue and $1.2 Million Net Income for Q3 2023, Continues Profitability Streak. Despite a slight decrease in revenue and net income for the quarter, year-to-date results show solid growth with $59.1 million in revenue and $3.7 million in net income. The Company maintains a strong balance sheet with $26.9 million in cash, cash equivalents, and short-term investments at the end of Q3 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.75%
Tags
Rhea-AI Summary
Vaso Corporation's application to trade on the OTCQX Best Market has been approved, marking an important milestone for the company. Trading on OTCQX could enhance shareholder value and increase trading liquidity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.7%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.7%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.67%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Vaso Corp

OTC:VASO

VASO Rankings

VASO Stock Data

45.58M
97.27M
44.52%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Plainview